Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Substances from stem cells for the treatment of (neuro-) degenerative diseases

02.11.2012
The new active agents can be used to produce

pharmaceutical substances to be used for the treatment of neurodegenerative diseases. The substances are enriched with dying stem cells. The agents are suited to disable

acute or delayed dysfunctions. They prevent the dying of neuronal cells after acute injuries or during the progress of neurodegenerative disorders.

Further Information: PDF

TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12

Contact
Dr. Peter Stumpf

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2960&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht Synthesis of novel Myrtucommulone and Analogues
25.11.2013 | TechnologieAllianz e.V.

nachricht Innovative nozzle design with homogeneous flow profile usable as divergent long-range nozzle with high penetration depth
22.11.2013 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

"Start-ups and spin-offs funding – Public and private policies", 14th October 2014

12.09.2014 | Event News

BALTIC 2014: Baltic Sea Geologists meet in Warnemünde

03.09.2014 | Event News

IT security in the digital society

27.08.2014 | Event News

 
Latest News

No sedative necessary: Scientists discover new “sleep node” in the brain

19.09.2014 | Life Sciences

Sensing Neuronal Activity With Light

19.09.2014 | Life Sciences

Miranda: An Icy Moon Deformed by Tidal Heating

19.09.2014 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>